Suchergebnisse - "Gossec, Laure"

PubPharm (5)

1

Guselkumab provides durable improvement across psoriatic arthritis disease domains : post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled study

enthalten in: RMD open | 2024

von Coates, L. | Gossec, L. | Zimmermann, M. | +8

2

Bimekizumab treatment in biologic DMARD-naïve patients with active psoriatic arthritis : 52-week efficacy and safety results from the phase III, randomised, placebo-controlled, active reference BE OPTIMAL study

enthalten in: Annals of the rheumatic diseases | 2023

von Ritchlin, C. | Coates, L. | McInnes, I. | +12

3

Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment : a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL)

enthalten in: Lancet (London, England) | 2023

von McInnes, I. | Asahina, A. | Coates, L. | +13

CommentIn: Lancet. 2023 Jan 7;401(10370):2-3. - PMID 36495880

4

Efficacy of a nurse-led patient education intervention in promoting safety skills of patients with inflammatory arthritis treated with biologics : a multicentre randomised clinical trial

enthalten in: RMD open | 2022

von Beauvais, C. | Fayet, F. | Rousseau, A. | +16

5

Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis : results of the open-label, pragmatic, cluster-randomised TICOSPA trial

enthalten in: Annals of the rheumatic diseases | 2021

von Molto, A. | López-Medina, C. | Van den Bosch, F. | +20

CommentIn: Ann Rheum Dis. 2021 Nov;80(11):1367-1369. - PMID 34144966

1
[1]